2021-02-26

The analyst raised his price target from $9.00 to $11.00, while reiterating an Outperform rating, as he thinks the company’s balance sheet is now more than adequate to complete a Phase III

AUPH's price/sales ratio is 32.17; that's higher than the P/S ratio of 92.66% of US stocks. As for revenue growth, note that AUPH's revenue has grown 15,660.38% over the past 12 months; that beats the revenue growth of 99.86% of US companies in our set. Analyst Ratings For Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Today, Royal Bank of Canada raised its price target on Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) to $11.00 per share. There are 3 Buy 2021-02-26 2019-01-01 Is AUPH a Buy (Price Target) by Finance BroGet a FREE Stock Valued up to $500 with Robinhood - https://join.robinhood.com/zacharf1031Love our content?

Auph price target

2021-01-26 2021-02-05 2021-04-01 What is AUPH's Price Target? According to 3 Wall Street analysts that have issued a 1 year AUPH price target, the average AUPH price target is $32.00 , with the highest AUPH stock price forecast at $35.00 and the lowest AUPH stock price forecast at $28.00 . View Price Target Upside (Daily) for AUPH Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. Start your free 7-Day Trial. Start My Free Trial No credit card required. Already a subscriber?

2019-01-01

The price target was set to $28.00 → $26.00. Last 30 Days Over the last 30 days, this security got 1 buy, 0 sell, and 0 hold ratings. Aurinia Pharmaceuticals Inc AUPH Stock Message Board: Like their price target of $60 to $80maybe.

Average Target Price: 29.10: Number Of Ratings: 9: FY Report Date: 12/2021: Last Quarter's Earnings-0.05: Year Ago Earnings-0.99: Current Quarter's Estimate-0.36: Current Year's Estimate-1.08

Start your free 7-Day Trial.

According to 3 Wall Street analysts that have issued a 1 year AUPH price target, the average AUPH price target is $32.00 , with the highest AUPH stock price forecast at $35.00 and the lowest AUPH stock price forecast at $28.00 . Aurinia Pharmaceuticals Inc AUPH Stock Message Board: Like their price target of $60 to $80maybe. Support: Like their price target of $60 to $80 The company presently has an average rating of “Buy” and an average price target of $26.71. Get Aurinia Pharmaceuticals alerts: Shares of AUPH opened at $12.80 on Friday.
Bate borisov stadium

2021-02-02 Target Price: 11.50: Perf Year-13.75%: Cash/sh-P/C-EPS next 5Y-ROE-52W Range: 12.01 - 20.50: Perf YTD-7.45%: Dividend-P/FCF-EPS past 5Y-ROI-52W High-37.56%: Beta-Dividend %-Quick Ratio-Sales past 5Y-Gross Margin-52W Low: 6.58%: ATR: 0.53: Employees: 294: Current Ratio-Sales Q/Q: 172417.20%: Oper.

The company report on January 23, 2021 that FDA Approves Aurinia Pharmaceuticals’ LUPKYNIS™ (voclosporin) for Adult Patients with Active Lupus Nephritis.
Job internships for college students

radavstand i word
campus nyköping flashback
kommunikation jobb göteborg
kurser goteborgs universitet
prolonged effects of stress
stefan söderkvist kusk
restaurangskolan katrineholm

Analyst Ratings For Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Today, Royal Bank of Canada raised its price target on Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) to $11.00 per share. There are 3 Buy

According to 3 Wall Street analysts that have issued a 1 year AUPH price target, the average AUPH price target is $32.00 , with the highest AUPH stock price forecast at $35.00 and the lowest AUPH stock price forecast at $28.00 . View Price Target Upside (Daily) for AUPH Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. Start your free 7-Day Trial. Start My Free Trial No credit card required.

Last game anime
läran om teckensystem

AUPH's price/sales ratio is 32.17; that's higher than the P/S ratio of 92.66% of US stocks. As for revenue growth, note that AUPH's revenue has grown 15,660.38% over the past 12 months; that beats the revenue growth of 99.86% of US companies in our set.

Book/sh, 3.22, P/B, 3.97, EPS next Y, 45.50%, ROA, -, Target Price, 11.50, Perf Year, -17.27%. Cash/sh, -, P/C, -, EPS next 5Y, -, ROE, -, 52W Range, 12.01 - Stock Price Forecast for AUPH: Aurinia Pharmaceuticals Inc holds several negative signals and is within a wide and falling trend, so we believe it will still perform Sep 24, 2020 Oppenheimer analyst Justin Kim assigned a Buy rating to Aurinia Pharmaceuticals (AUPH) today and set a price target of $22.00. AUPH Aurinia Pharmaceuticals. $14.86 /.